Regulation of HIF-1α Stability through S-Nitrosylation

Molecular Cell

Volumn 26, Issue 1, 2007, Pages 63-74

  Li, Fang ^a   Sonveaux, Pierre ^b,c   Rabbani, Zahid N ^c   Liu, Shanling ^c,d   Yan, Bin ^c   Huang, Qian ^e   Vujaskovic, Zeljko ^c   Dewhirst, Mark W ^c   Li, Chuan Yuan ^a,c  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d SICHUAN UNIVERSITY   (China)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

SIGNALING

Indexed keywords

CYSTEINE; HYPOXIA INDUCIBLE FACTOR 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; CONTROLLED STUDY; IONIZING RADIATION; MELANOMA; MOUSE; NITROSYLATION; NONHUMAN; PROTEIN DOMAIN; PROTEIN STABILITY; UPREGULATION; AMINO ACID SEQUENCE; ANIMAL; BIOLOGICAL MODEL; CELL CULTURE; CHEMISTRY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; MACROPHAGE; METABOLISM; MOLECULAR GENETICS; MUTATION; NEOPLASM; RADIATION EXPOSURE; SEQUENCE HOMOLOGY; TUMOR CELL LINE;

MAMMALIA; MURINAE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; CYSTEINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACROPHAGES; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

EID: 34047272690     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2007.02.024     Document Type: Article

References (54)

1. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357 (2001) 593-615
2. Bisht K.S., Bradbury C.M., Mattson D., Kaushal A., Sowers A., Markovina S., Ortiz K.L., Sieck L.K., Isaacs J.S., Brechbiel M.W., et al. Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity. Cancer Res. 63 (2003) 8984-8995
3. Brizel D.M., Scully S.P., Harrelson J.M., Layfield L.J., Dodge R.K., Charles H.C., Samulski T.V., Prosnitz L.R., and Dewhirst M.W. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas. Cancer Res. 56 (1996) 5347-5350
4. Colombo M.P., and Mantovani A. Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion. Cancer Res. 65 (2005) 9113-9116
5. Cramer T., and Johnson R.S. A novel role for the hypoxia inducible transcription factor HIF-1alpha: critical regulation of inflammatory cell function. Cell Cycle 2 (2003) 192-193
6. Cramer T., Yamanishi Y., Clausen B.E., Forster I., Pawlinski R., Mackman N., Haase V.H., Jaenisch R., Corr M., Nizet V., et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112 (2003) 645-657
7. Dote H., Burgan W.E., Camphausen K., and Tofilon P.J. Inhibition of hsp90 compromises the DNA damage response to radiation. Cancer Res. 66 (2006) 9211-9220
8. Garcia-Barros M., Paris F., Cordon-Cardo C., Lyden D., Rafii S., Haimovitz-Friedman A., Fuks Z., and Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300 (2003) 1155-1159
9. Gaston B.M., Carver J., Doctor A., and Palmer L.A. S-nitrosylation signaling in cell biology. Mol. Interv. 3 (2003) 253-263
10. Giaccia A., Siim B.G., and Johnson R.S. HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2 (2003) 803-811
11. Goldmann O., Rohde M., Chhatwal G.S., and Medina E. Role of macrophages in host resistance to group A streptococci. Infect. Immun. 72 (2004) 2956-2963
12. Harris A.L. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2 (2002) 38-47
13. Isaacs J.S., Jung Y.J., and Neckers L. Aryl hydrocarbon nuclear translocator (ARNT) promotes oxygen-independent stabilization of hypoxia-inducible factor-1alpha by modulating an Hsp90-dependent regulatory pathway. J. Biol. Chem. 279 (2004) 16128-16135
14. Ivan M., Kondo K., Yang H., Kim W., Valiando J., Ohh M., Salic A., Asara J.M., Lane W.S., and Kaelin Jr. W.G. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292 (2001) 464-468
15. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
16. Jaffrey S.R., and Snyder S.H. The biotin switch method for the detection of S-nitrosylated proteins. Sci. STKE 2001 (2001) PL1 10.1126/stke.2001.86.pl1 Published online June 12, 2001
17. Jeong J.W., Bae M.K., Ahn M.Y., Kim S.H., Sohn T.K., Bae M.H., Yoo M.A., Song E.J., Lee K.J., and Kim K.W. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell 111 (2002) 709-720
18. Jung F., Palmer L.A., Zhou N., and Johns R.A. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ. Res. 86 (2000) 319-325
19. Lando D., Peet D.J., Gorman J.J., Whelan D.A., Whitelaw M.L., and Bruick R.K. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16 (2002) 1466-1471
20. Lando D., Peet D.J., Whelan D.A., Gorman J.J., and Whitelaw M.L. Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295 (2002) 858-861
21. Leek R.D., Hunt N.C., Landers R.J., Lewis C.E., Royds J.A., and Harris A.L. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J. Pathol. 190 (2000) 430-436
22. Leek R.D., Talks K.L., Pezzella F., Turley H., Campo L., Brown N.S., Bicknell R., Taylor M., Gatter K.C., and Harris A.L. Relation of hypoxia-inducible factor-2 alpha (HIF-2 alpha) expression in tumor-infiltrative macrophages to tumor angiogenesis and the oxidative thymidine phosphorylase pathway in Human breast cancer. Cancer Res. 62 (2002) 1326-1329
23. Lewis C., and Murdoch C. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am. J. Pathol. 167 (2005) 627-635
24. Maltepe E., Schmidt J.V., Baunoch D., Bradfield C.A., and Simon M.C. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386 (1997) 403-407
25. Matrone C., Pignataro G., Molinaro P., Irace C., Scorziello A., Di Renzo G.F., and Annunziato L. HIF-1alpha reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion. J. Neurochem. 90 (2004) 368-378
26. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., and Ratcliffe P.J. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
27. Maxwell P.H., Pugh C.W., and Ratcliffe P.J. The pVHL-hIF-1 system. A key mediator of oxygen homeostasis. Adv. Exp. Med. Biol. 502 (2001) 365-376
28. Melillo G. HIF-1: a target for cancer, ischemia and inflammation-too good to be true?. Cell Cycle 3 (2004) 154-155
29. Melillo G., Taylor L.S., Brooks A., Musso T., Cox G.W., and Varesio L. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 272 (1997) 12236-12243
30. Metzen E., Zhou J., Jelkmann W., Fandrey J., and Brune B. Nitric oxide impairs normoxic degradation of HIF-1alpha by inhibition of prolyl hydroxylases. Mol. Biol. Cell 14 (2003) 3470-3481
31. Moeller B.J., Cao Y., Li C.Y., and Dewhirst M.W. Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5 (2004) 429-441
32. Moeller B.J., Dreher M.R., Rabbani Z.N., Schroeder T., Cao Y., Li C.Y., and Dewhirst M.W. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 8 (2005) 99-110
33. Muller A.J., DuHadaway J.B., Donover P.S., Sutanto-Ward E., and Prendergast G.C. Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy. Nat. Med. 11 (2005) 312-319
34. Neckers L., and Ivy S.P. Heat shock protein 90. Curr. Opin. Oncol. 15 (2003) 419-424
35. Neckers L., and Neckers K. Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents. Expert Opin. Emerg. Drugs 7 (2002) 277-288
36. Palmer L.A., Gaston B., and Johns R.A. Normoxic stabilization of hypoxia-inducible factor-1 expression and activity: redox-dependent effect of nitrogen oxides. Mol. Pharmacol. 58 (2000) 1197-1203
37. Pause A., Peterson B., Schaffar G., Stearman R., and Klausner R.D. Studying interactions of four proteins in the yeast two-hybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein. Proc. Natl. Acad. Sci. USA 96 (1999) 9533-9538
38. Peyssonnaux C., Datta V., Cramer T., Doedens A., Theodorakis E.A., Gallo R.L., Hurtado-Ziola N., Nizet V., and Johnson R.S. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115 (2005) 1806-1815
39. Rapisarda A., Uranchimeg B., Scudiero D.A., Selby M., Sausville E.A., Shoemaker R.H., and Melillo G. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 62 (2002) 4316-4324
40. Sandau K.B., Fandrey J., and Brune B. Accumulation of HIF-1alpha under the influence of nitric oxide. Blood 97 (2001) 1009-1015
41. Semenza G.L. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8 (2002) S62-S67
42. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
43. Semenza G.L., Agani F., Feldser D., Iyer N., Kotch L., Laughner E., and Yu A. Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv. Exp. Med. Biol. 475 (2000) 123-130
44. Sutphin P.D., Chan D.A., and Giaccia A.J. Dead cells don't form tumors: HIF-dependent cytotoxins. Cell Cycle 3 (2004) 160-163
45. Thomas D.D., Espey M.G., Ridnour L.A., Hofseth L.J., Mancardi D., Harris C.C., and Wink D.A. Hypoxic inducible factor 1alpha, extracellular signal-regulated kinase, and p53 are regulated by distinct threshold concentrations of nitric oxide. Proc. Natl. Acad. Sci. USA 101 (2004) 8894-8899
46. Thomsen L.L., Scott J.M., Topley P., Knowles R.G., Keerie A.J., and Frend A.J. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res. 57 (1997) 3300-3304
47. Varney M.L., Olsen K.J., Mosley R.L., Bucana C.D., Talmadge J.E., and Singh R.K. Monocyte/macrophage recruitment, activation and differentiation modulate interleukin-8 production: a paracrine role of tumor-associated macrophages in tumor angiogenesis. In Vivo 16 (2002) 471-477
48. Wachsberger P., Burd R., and Dicker A.P. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clin. Cancer Res. 9 (2003) 1957-1971
49. Wang G.L., and Semenza G.L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268 (1993) 21513-21518
50. Wang G.L., and Semenza G.L. General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc. Natl. Acad. Sci. USA 90 (1993) 4304-4308
51. Wang G.L., and Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270 (1995) 1230-1237
52. Yasinska I.M., and Sumbayev V.V. S-nitrosation of Cys-800 of HIF-1alpha protein activates its interaction with p300 and stimulates its transcriptional activity. FEBS Lett. 549 (2003) 105-109
53. Yeo E.J., Chun Y.S., Cho Y.S., Kim J., Lee J.C., Kim M.S., and Park J.W. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1. J. Natl. Cancer Inst. 95 (2003) 516-525
54. Zhang X., Kon T., Wang H., Li F., Huang Q., Rabbani Z.N., Kirkpatrick J.P., Vujaskovic Z., Dewhirst M.W., and Li C.Y. Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha. Cancer Res. 64 (2004) 8139-8142